Immunoreactive LH-RH was present in all the hypothalamic and cortical extracts of mid-term human fetuses studied and in the cortical tissue removed from the two youngest fetuses. Gonadotrophin-releasing activity of hypothalamic and cortical extracts was demonstrated by the significant rises of circulating LH after infusion into oestrogen and progesterone-primed ovariectomized rats.
Introduction
Although immunoreactive LH-RH has recently been identified in human fetal brain tissue from as early as 4-5 weeks after conception (Winters, Eskay & Porter, 1974) there is little information existing as to the exact time at which pituitary gonadotrophin synthesis and release commences. Siler-Khodr, Morgenstern & Greenwood (1974) have claimed that both pituitary LH and FSH are present within 5 weeks of conception and Tamura, Minaguchi & Sakamonto (1973) have shown that when second trimester human pituitaries are grown in organ culture LH may be released spontaneously or by the addition of synthetic LH-RH to the medium. However, an investigation in vivo by Gennser, Liedholm & Thorell (1976) failed to note any change in plasma gonadotrophins when LH-RH was administered to fetuses at 15-22 weeks of gestation. The purpose of the present study was (1) to investigate further the presence of LH-RH in human fetal hypothalamic and cortical tissue by direct radioimmunoassay and (2) to examine the gonadotrophin-releasing activity of these same extracts when infused into the carotid artery of suitably primed ovariectomized rats.
Materials and Methods
Sixteen mid-termhuman fetuses, ranging in size from 46 to 179 mm crown-rump length, were collected within 5-10 min of their removal from the uterus by hysterotomy (performed for gynaecological reasons on otherwise healthy pregnant women). Fetal age was assessed by comparing weight and crown-rump length with those in the tables published by Iffy et al (1975) . Sex was determined by examination of the external and internal genitalia and confirmed by subsequent gonadal histology. The hypothalamus and a sample of cortical tissue from the frontal lobe were removed and immediately frozen on solid C02 before storage at -20°C. Extracts were later prepared by thawing the samples and adding 1-0 ml 0-5 % HC1 for every 100 mg tissue present. The mixture was homogenized and centri¬ fuged at 0°C and the supernatant was neutralized with solid NaHC03 before being frozen and stored. Each preparation yielded beftween 1 -0 and 2-0 ml extract. Experiment 1. Detection offetal LH-RH Samples (0-5 ml) of hypothalamic and cortical extracts from 8 fetuses were individually thawed and then chromatographed on a Biogel P2 column (32-5 1 cm) with 2-5 % human serum albumin and 0-05 M-Na2PO_ buffer (pH 7-5) at a flow rate of 3 ml/h. Fractions of 0-5 ml were collected and LH-RH *Present address: Royal Maternity Hospital, Rottenrow, Glasgow, U.K. tPresent address: M.R.C. Unit of Reproductive Biology, Forrest Road, Edinburgh, U.K.
was measured with the highly sensitive radioimmunoassay developed by Mortimer et al (1976) , in which the minimal detectable LH-RH titre is 0-2 pg/ml. The assays were performed in duplicate; the intra-and inter-assay coefficients of variation were 12 and 15-5% respectively. Extracts of rat stalk-median eminence (SME) were prepared in the same manner as the human tissue and the elution patterns for synthetic LH-RH in buffer, rat SME and human fetal hypothalami were similar and are shown in Text- fig Experiment 2. Assessment offetal LH-RH activity Other samples (1-0 ml) of hypothalamic and cortical extracts from all 16 fetuses were thawed and each was then infused under ether anaesthesia into the carotid artery ofa mature heparinized Sprague-Dawley rat. Infusions of 10 ml of carrier solution (neutralized HC1) were carried out as controls and carrier solution containing synthetic LH-RH in concentrations ranging from 0-2 pg to 200 ng/ml was administered to investigate dose-related responses. All 66 rats used were sexually mature and had been ovariectomized for at least 4 weeks. Priming doses of 50 µg oestradiol benzoate and 25 mg progester¬ one in 1 -0 ml corn oil were injected subcutaneously 72 h before the experiment because pretreatment with these steroids has been shown to sensitize ovariectomized rats to the action of exogenous LH-RH (Ramirez & McCann, 1963) . Blood was collected from the iliac vein immediately before and at 15 min after infusions. Concentrations of LH and FSH were measured in the separated plasma by a doubleantibody radioimmunoassay using material supplied by the NIAMDD, Bethesda, Maryland. The intra-assay coefficient of variation was 8% for LH and 10% for FSH. The inter-assay coefficient of variation was 12 % for LHand 15 % for FSH. The results are expressed as ng equivalents ofNIAMDD-LH-RP-1 or NIAMDD-FSH-RP-1 /ml. The limits of detection were established as 4 ng/ml for LH and 40 ng/ml for FSH.
Results
Experiment 1 LH-RH was detected by radioimmunoassay in all the fetal hypothalamic samples (Table 1) . The concentration was highest in the preparations from the two youngest fetuses, and it was only from these that the cortical samples contained any detectable amounts of LH-RH. The effects on rat plasma gonadotrophin levels of the carotid infusions are shown in Table 2 and in Text-figs 2 and 3. The results were analysed statistically by a number of two-sample t tests. Doses of LH-RH ranging from 2 to 200 ng and the infusions of hypothalamic extract all brought about a significant elevation of plasma LH (P < 0001) in comparison to the rise induced in the controls treated with neutralized HC1. The increase in circulating LH caused by infusion ofcortical extract was also significant (P < 0-05), but to a lesser degree. However, only the highest dose of the synthetic decapeptide significantly raised plasma FSH concentrations (P < 0-05). 2x10" LH-RH dose (pg) Text- fig. 2 . Increments (mean ± s.e.m.) in plasma LH of oestrogen and progesterone-primed ovariecto¬ mized rats infused with various doses of LH-RH, neutralized HC1 and fetal hypothalamic and cortical extracts (see Table 2 for numbers of animals). 
Discussion
The differential effect of LH-RH on plasma LH and FSH levels is in broad agreement with the results ofLibertun, Cooper, Fawcett & McCann (1974) who found no significant effects on plasma FSH when rats were treated with various doses of LH-RH.
Few pregnancies in women are now terminated by hysterotomy and investigations into human prenatal endocrinology are therefore limited by the availability of tissue. Although there are in¬ sufficient data from the present study to permit any firm comments about the pattern of LH-RH content and activity in relation to fetal age and sex, it would appear that the concentrations of the hormone measured in the hypothalamus and cortex (Table 1) are not necessarily correlated with the hormonal activity demonstrated by bioassay (Text-fig. 2 ). Fetal hypothalamic and cortical tissues appear to contain much higher amounts of LH-RH than are measured by radioimmunoassay in any of the samples collected. However, estimates of LH-RH activity in the human brain by using a bio¬ assay must be made with some caution because the decapeptide has not been established as the sole biologically active form of the gonadotrophin-releasing hormone. Certain fragments of the decapep¬ tide have been shown by Debeljuk, Arimura & Schally (1973) to have biological activity and it is possible that these fragments may be present in proportionally greater concentrations in the fetal than in the adult brain. Moreover, as pointed out by Seyler & Reichlin (1974) , the bioassay dose-response curves for LH-RH extracted from rat, porcine and human hypothalami differ from those with the synthetic hormone.
Although the presence of LH-RH has been identified in the early and mid-term human fetal brain, the experiments of Gennser et al (1976) have demonstrated that the human fetal pituitary in vivo is unable to respond to exogenous LH-RH ; endogenous LH-RH may also therefore be incapable of stimulating gonadotrophin release. However, the experiments reported here have shown that extracts of fetal hypothalamus and cortex containing this releasing hormone do at least exhibit biological activity when injected into suitably primed rats.
